Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05910931

Efficacy of Angiography With Indocyanine Green in the Identification of Complications After Breast Surgery

Sponsor: University Hospital A Coruña

View on ClinicalTrials.gov

Summary

During the performance of oncoplastic surgery and skin-sparing or skin-nipple mastectomy there is a significant loss in the perfusion of the cutaneous envelope of the breast, which can produce areas of vascular suffering of the skin that sometimes cause necrosis of the same. Skin necrosis is the most important adverse event in oncoplastic and reconstructive surgery of the breast, since it causes delays in adjuvant treatments to surgery, worsening of the cosmetic result, and, on occasions, loss of the implant and reconstruction. Indocyanine color green (ICG) angiography has been proposed as a diagnostic alternative to determine the vascular perfusion of the skin envelope of the breast during surgery, which would allow the removal of tissue at risk of necrosis to avoid this complication during the postoperative period. However, the scientific literature does not currently allow an adequate assessment of this diagnostic procedure due to the absence of prospective studies that have evaluated its sensitivity, specificity, and predictive values. The objective of this prospective study is to evaluate ICG angiography of skin flaps of the breast and the surgeon's decision in women with breast cancer or at high risk for breast cancer undergoing oncoplastic surgery or mastectomy with the help of skin or skin-nipple. Based on the results of this study, the sensitivity, specificity, and predictive values of this technique for the prediction of adverse events during the postoperative period will be established.

Official title: Prospective Study for the Evaluation of the Efficacy and Concordance of Angiography With Indocyanine Green in the Identification of Complications After Oncoplastic Surgery and Skin and Nipple-skin Sparing Mastectomy

Key Details

Gender

FEMALE

Age Range

18 Years - 100 Years

Study Type

OBSERVATIONAL

Enrollment

221

Start Date

2023-06-01

Completion Date

2025-07-31

Last Updated

2024-07-23

Healthy Volunteers

No

Interventions

DRUG

ICG angiography

* A first injection with the patient asleep before starting the intervention to visualize the vascular anatomy of each patient and assess the pedicles and incisions. * A second bolus after breast resection to assess the viability of skin flaps and glandular pedicles. * A third injection to obtain an angiography after implant placement and wound closure. For angiography, the SPY System with the SPY-Q software will be used.

Locations (1)

Hospital Abente y Lago

A Coruña, Spain